[BidClub_]

SHOW DIRECTORY

Sourcery

Molly O'Shea interviews leading investors, CEOs, and founders about technology companies, markets, and company building.

SOURCE DESCRIPTION · RSS

41 EPISODESENTRACKED SHOW
SUBSCRIBE[Feed_]
17 episodes2 active
Language
SourceryEN · 56 min

Apollo’s Yahoo Playbook, 5 Years After the $5B Deal

Jim LanzoneMolly O'Shea

Lanzone says Apollo has largely recovered its $4.8 billion Yahoo cost through early cash returns and disposals including AOL.The reset shut loss-making ad tech that cost hundreds of millions annually and opened inventory to competing demand, while retaining DSP.Scout restores owned search, but Lanzone makes no IPO commitment and hesitates to call Yahoo’s audience distribution a moat.

SourceryEN · 70 min

Thrive Capital’s Dr. Nworah Ayogu on Why Neuralink Is More Interesting Than SpaceX

Molly O'SheaNworah Ayogu

Thrive’s healthcare thesis is that AI may shift bottlenecks from molecule generation to validation, trials, manufacturing, and commercialization.Cadence cites 25% fewer hospitalizations, over-80% more controlled-blood-pressure patients, nearly one-point lower A1C, and $2.5 million in weekly Medicare savings across 100,000+ monitored patients.Neuralink and OpenAI show upside, while clinical processes and manufacturing capacity remain unresolved constraints.

SourceryEN · 85 min

USV’s New $900M Fund: Fred Wilson, Rebecca Kaden & Mike Mignano

Fred WilsonRebecca KadenMichael MignanoMolly O'Shea

USV’s $900 million fund targets 30-40 companies with $10 million-$30 million Series A checks as larger rounds and scaling costs reshape venture.Its AI thesis spans applications, infrastructure, physical AI, and energy, while usage retention, compute costs, inference subsidies, distribution, interoperability, trust, and leadership concentration remain key tests.

SourceryEN · 58 min

Annie Lamont: $14B Managed, 70+ Exits, 15 IPOs, 7x Midas Investor

Jonathan SiddharthMolly O'Shea

Healthcare AI has crossed O'Shea’s threshold for measurable impact, with biological and chemical models, laboratory robotics and simulations targeting drug development’s high failure rates.After a decade building licenses, networks and care infrastructure, Devoted Health tripled in size, halved operating expenses and significantly increased EBITDA, while China’s rising pharmaceutical research share leaves domestic research and regulatory capacity as risks to monitor.

SourceryEN · 75 min

Bending Spoons Is Coming for Silicon Valley, with CEO Luca Ferrari

Luca FerrariMolly O'Shea

Bending Spoons’ edge is an integrated operating model that standalone owners cannot economically reproduce.Its 50-plus proprietary technologies, nearly 1,000-person core team, and debt-funded permanent ownership support claimed annual savings above $100 million and $4 million revenue per core Spooner.Airtable’s approximately $1.3 billion enterprise value reflects the underwriting test, while AI startup valuations and unmeasured AI capabilities remain key risks to monitor.

SourceryEN · 69 min

BlackRock's Tony Kim on AI's Next Winners?

Tony KimMolly O'Shea

AI has shifted value toward chips and hardware, with Kim estimating $30T+ there versus roughly $10T across software/services/internet.Base compute has jumped 10,000×, while the rebuild may require a trillion dollars this year and ten trillion over five years.Token factories may compress SaaS margins; memory and foundation-lab IPOs are watchpoints as Kim says his thesis may change.

SourceryEN · 59 min

From $18B to $300B: How Nikesh Arora Rebuilt Palo Alto Networks

Molly O'SheaNikesh Arora

AI is compressing zero-day remediation from 55 days to Palo Alto Networks’ four-hour patch delivery, forcing infrastructure modernization.Mythos has moved cybersecurity to the CEO agenda, directing demand toward existing partners and structurally favoring incumbents.Arora sees cybersecurity’s SaaSpocalypse as over, but expects markets to become more discerning in roughly two years as perfect-execution pricing meets stumbles.

SourceryEN · 69 min

BlackRock's Tony Kim on AI's Next Winners? Chips, Memory, Robotics & Quantum

Tony KimMolly O'Shea

AI has reset the market toward compute hardware, with Kim estimating more than $30T in chips and hardware versus roughly $10T in software, services, and internet.The resulting $1T of CapEx this year and $10T over five years is moving data centimeters and millimeters, but three-to-four-year fab cycles face memory shortages, making 2030 milestones such as quantum and orbital data centers key watchpoints.

SourceryEN · 57 min

Benchmark's AI Bets: Cerebras, Sierra, Legora, Fireworks, Starcloud, Gumloop..

Everett RandleMolly O'Shea

AI is breaking the spreadsheet playbook: billion-dollar businesses can still lack unit economics or durable differentiation, and scale may increase impairment risk.Inference monetization can drive revenue from 1 to 30 to 300, while agents shift purchases toward intelligence or economic output.Frontier labs retain pricing power if recursive self-improvement works, but face a 95%-as-good open-source squeeze if capabilities plateau.

SourceryEN · 57 min

General Catalyst's First-Ever Quarterly Review | CEO Hemant Taneja

Hemant TanejaMolly O'Shea

Anthropic is adding $10 billion of revenue a month and NVIDIA added $1 trillion of market cap in 100 days, highlighting AI-era scale concentration.GC’s counter-bet spans seed, Creation, and Customer Value Fund strategies, while 15x-to-3x revenue-multiple compression could leave even doubled-EBITDA software equity unrecovered.Leverage coming due in the next five years makes AI transformation opportunities and durability uncertainty key variables to monitor.